{"id":76110,"date":"2026-04-24T10:45:00","date_gmt":"2026-04-24T05:15:00","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=76110"},"modified":"2026-04-24T10:45:02","modified_gmt":"2026-04-24T05:15:02","slug":"krsnaa-diagnostics-q4-results-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/","title":{"rendered":"Krsnaa Diagnostics Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook"},"content":{"rendered":"<p>Krsnaa Diagnostics (KRSNAA) is set to announce its Q4 FY26 results in May 2026. Investors and market participants are keenly watching the upcoming quarterly numbers for one of India&#8217;s well-known Healthcare and Diagnostics companies. The Q4 FY26 earnings season is a critical period for equity markets as full-year financial performance comes into sharper focus.<\/p>\n<p>Analyst consensus estimates project Krsnaa Diagnostics Q4 FY26 revenue at Rs 308 Cr, representing a year-on-year growth of approximately 10%, while PAT is estimated at Rs 34 Cr, a growth of approximately 21% compared to the same quarter in FY25. These estimates reflect the sector outlook and company-specific operational momentum observed over the preceding quarters.<\/p>\n<p>In this article, we provide a detailed preview of Krsnaa Diagnostics Q4 results 2026, including the expected date, key financial estimates, five growth factors, five risks and the latest analyst ratings. Get free investment insights on <a href=\"https:\/\/univest.in\/user\/log-in\">Univest<\/a> to stay ahead of earnings season.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#Krsnaa_Diagnostics_Q4_Results_2026_Date\" title=\"Krsnaa Diagnostics Q4 Results 2026 Date\">Krsnaa Diagnostics Q4 Results 2026 Date<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#Why_This_Quarter_Matters_for_Krsnaa_Diagnostics\" title=\"Why This Quarter Matters for Krsnaa Diagnostics\">Why This Quarter Matters for Krsnaa Diagnostics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#Krsnaa_Diagnostics_Q4_FY26_Earnings_Estimates\" title=\"Krsnaa Diagnostics Q4 FY26 Earnings Estimates\">Krsnaa Diagnostics Q4 FY26 Earnings Estimates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#5_Key_Factors_That_Will_Drive_Krsnaa_Diagnostics_Q4_FY26_Performance\" title=\"5 Key Factors That Will Drive Krsnaa Diagnostics Q4 FY26 Performance\">5 Key Factors That Will Drive Krsnaa Diagnostics Q4 FY26 Performance<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#1_Preventive_Healthcare_Demand\" title=\"1. Preventive Healthcare Demand\">1. Preventive Healthcare Demand<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#2_Network_Expansion_into_Tier-2_and_Tier-3_Cities\" title=\"2. Network Expansion into Tier-2 and Tier-3 Cities\">2. Network Expansion into Tier-2 and Tier-3 Cities<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#3_Specialised_Testing_Growth\" title=\"3. Specialised Testing Growth\">3. Specialised Testing Growth<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#4_Institutional_and_B2B_Business\" title=\"4. Institutional and B2B Business\">4. Institutional and B2B Business<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#5_Digital_Health_Platform_Integration\" title=\"5. Digital Health Platform Integration\">5. Digital Health Platform Integration<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#5_Risks_to_Watch_in_Krsnaa_Diagnostics_Q4_FY26\" title=\"5 Risks to Watch in Krsnaa Diagnostics Q4 FY26\">5 Risks to Watch in Krsnaa Diagnostics Q4 FY26<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#1_Price_War_from_Competition\" title=\"1. Price War from Competition\">1. Price War from Competition<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#2_Regulatory_Quality_Requirements\" title=\"2. Regulatory Quality Requirements\">2. Regulatory Quality Requirements<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#3_Capital_Intensity_of_Network_Expansion\" title=\"3. Capital Intensity of Network Expansion\">3. Capital Intensity of Network Expansion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#4_Equipment_Upgrade_Capex\" title=\"4. Equipment Upgrade Capex\">4. Equipment Upgrade Capex<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#5_Insurance_Reimbursement_Pressure\" title=\"5. Insurance Reimbursement Pressure\">5. Insurance Reimbursement Pressure<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#Krsnaa_Diagnostics_Share_Price_and_Analyst_Ratings\" title=\"Krsnaa Diagnostics Share Price and Analyst Ratings\">Krsnaa Diagnostics Share Price and Analyst Ratings<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#What_is_the_Krsnaa_Diagnostics_Q4_results_2026_date\" title=\"What is the Krsnaa Diagnostics Q4 results 2026 date?\">What is the Krsnaa Diagnostics Q4 results 2026 date?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#What_is_the_Krsnaa_Diagnostics_Q4_FY26_PAT_estimate\" title=\"What is the Krsnaa Diagnostics Q4 FY26 PAT estimate?\">What is the Krsnaa Diagnostics Q4 FY26 PAT estimate?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#What_is_Krsnaa_Diagnostics_share_price_ahead_of_Q4_results\" title=\"What is Krsnaa Diagnostics share price ahead of Q4 results?\">What is Krsnaa Diagnostics share price ahead of Q4 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#Will_Krsnaa_Diagnostics_declare_a_dividend_in_Q4_2026\" title=\"Will Krsnaa Diagnostics declare a dividend in Q4 2026?\">Will Krsnaa Diagnostics declare a dividend in Q4 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#Which_analysts_have_a_Buy_rating_on_Krsnaa_Diagnostics\" title=\"Which analysts have a Buy rating on Krsnaa Diagnostics?\">Which analysts have a Buy rating on Krsnaa Diagnostics?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#What_were_Krsnaa_Diagnostics_Q3_FY26_results\" title=\"What were Krsnaa Diagnostics Q3 FY26 results?\">What were Krsnaa Diagnostics Q3 FY26 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#When_do_Infosys_and_TCS_announce_Q4_results_2026\" title=\"When do Infosys and TCS announce Q4 results 2026?\">When do Infosys and TCS announce Q4 results 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#Is_Krsnaa_Diagnostics_a_good_investment_ahead_of_Q4_results\" title=\"Is Krsnaa Diagnostics a good investment ahead of Q4 results?\">Is Krsnaa Diagnostics a good investment ahead of Q4 results?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/krsnaa-diagnostics-q4-results-2026\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Krsnaa_Diagnostics_Q4_Results_2026_Date\"><\/span><strong>Krsnaa Diagnostics Q4 Results 2026 Date<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Access premium research and earnings previews on <a href=\"https:\/\/univest.in\/user\/log-in\">Univest<\/a> before every major result announcement.<\/p>\n<p>The Krsnaa Diagnostics Q4 FY26 results are expected to be declared in May 2026. The board of directors will convene a meeting to approve the audited financial results for the quarter and full year ended March 31, 2026. The exact date will be intimated through BSE and NSE filings. Investors should monitor exchange announcements for the confirmed date.<\/p>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<td><strong>Company<\/strong><\/td>\n<td><strong>Q4 Results Date<\/strong><\/td>\n<td><strong>Key Watch<\/strong><\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/blogs\/tcs-q4-results-2026-date-preview\">TCS<\/a><\/td>\n<td>April 9, 2026<\/td>\n<td>Revenue growth and deal wins<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/blogs\/infosys-q4-results-2026-date-preview\">Infosys<\/a><\/td>\n<td>April 23, 2026<\/td>\n<td>FY27 guidance and margin outlook<\/td>\n<\/tr>\n<tr>\n<td>Krsnaa Diagnostics<\/td>\n<td>May 2026 (Expected)<\/td>\n<td>Revenue, PAT and dividend announcement<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Why_This_Quarter_Matters_for_Krsnaa_Diagnostics\"><\/span><strong>Why This Quarter Matters for Krsnaa Diagnostics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>India&#8217;s healthcare diagnostics sector maintains solid growth momentum in Q4 FY26, backed by rising health awareness, insurance penetration expansion and a robust preventive testing trend driving test volumes across the country.<\/p>\n<p>For Krsnaa Diagnostics specifically, Q4 FY26 is a critical quarter as it determines the full-year FY26 performance trajectory. The management&#8217;s commentary on FY27 outlook, any guidance revision and dividend announcement will be equally important for investor sentiment as the headline revenue and PAT numbers.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Krsnaa_Diagnostics_Q4_FY26_Earnings_Estimates\"><\/span><strong>Krsnaa Diagnostics Q4 FY26 Earnings Estimates<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Screen Krsnaa Diagnostics fundamentals, historical financials and technical indicators on <a href=\"https:\/\/univest.in\/screeners\">Univest Screener<\/a>.<\/p>\n<p>Based on analyst consensus and sector-level research, Krsnaa Diagnostics is expected to report Q4 FY26 revenue of Rs 308 Cr, up 10% year-on-year. PAT is estimated at Rs 34 Cr, reflecting 21% growth. EBITDA margin is expected to come in at approximately 11.0%, showing improvement compared to the year-ago quarter driven by operating leverage and cost efficiencies.<\/p>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<td><strong>Metric<\/strong><\/td>\n<td><strong>Q3 FY26 (Actual)<\/strong><\/td>\n<td><strong>Q4 FY26 (Estimate)<\/strong><\/td>\n<td><strong>YoY Change<\/strong><\/td>\n<\/tr>\n<tr>\n<td>Revenue (Rs Cr)<\/td>\n<td>280<\/td>\n<td>308<\/td>\n<td>+10% (Est)<\/td>\n<\/tr>\n<tr>\n<td>PAT (Rs Cr)<\/td>\n<td>28<\/td>\n<td>34<\/td>\n<td>+21% (Est)<\/td>\n<\/tr>\n<tr>\n<td>PAT Margin (%)<\/td>\n<td>10.0%<\/td>\n<td>11.0%<\/td>\n<td>Expanding<\/td>\n<\/tr>\n<tr>\n<td>Dividend History<\/td>\n<td colspan=\"2\">Nil<\/td>\n<td>&#8211;<\/td>\n<\/tr>\n<tr>\n<td>Dividend Expectation<\/td>\n<td colspan=\"2\">Nil expected<\/td>\n<td>&#8211;<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Beyond the headline numbers, key metrics to watch include EBITDA margin trajectory, working capital management, order book or pipeline commentary and management guidance for FY27. These forward-looking indicators often have a larger impact on stock price reaction than the reported PAT figure alone.<\/p>\n<p>Track Krsnaa Diagnostics fundamentals and compare it with sector peers on <a href=\"https:\/\/univest.in\/screeners\">Univest Screener<\/a> for in-depth financial analysis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"5_Key_Factors_That_Will_Drive_Krsnaa_Diagnostics_Q4_FY26_Performance\"><\/span><strong>5 Key Factors That Will Drive Krsnaa Diagnostics Q4 FY26 Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_Preventive_Healthcare_Demand\"><\/span><strong>1. Preventive Healthcare Demand<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Growing health consciousness and rising insurance coverage are driving strong demand for health checkup packages and chronic disease monitoring tests, both of which carry higher margins.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Network_Expansion_into_Tier-2_and_Tier-3_Cities\"><\/span><strong>2. Network Expansion into Tier-2 and Tier-3 Cities<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Diagnostic chains are capturing untapped demand in semi-urban India through hub-and-spoke lab models and home collection services, expanding addressable market significantly.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Specialised_Testing_Growth\"><\/span><strong>3. Specialised Testing Growth<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>High-value testing in genomics, immunology, molecular diagnostics and oncology is growing rapidly, improving revenue per patient and blended margin profiles.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_Institutional_and_B2B_Business\"><\/span><strong>4. Institutional and B2B Business<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Tie-ups with hospitals, corporates and insurance companies for dedicated diagnostic services create stable, recurring B2B revenue with lower customer acquisition costs.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_Digital_Health_Platform_Integration\"><\/span><strong>5. Digital Health Platform Integration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Digital booking, home collection and online reporting platforms are improving patient experience, loyalty and repeat testing rates, reducing churn and acquisition costs.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"5_Risks_to_Watch_in_Krsnaa_Diagnostics_Q4_FY26\"><\/span><strong>5 Risks to Watch in Krsnaa Diagnostics Q4 FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_Price_War_from_Competition\"><\/span><strong>1. Price War from Competition<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Aggressive discounting by unorganised labs and newer entrant chains pressures realisations and tests-per-patient metrics across markets.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Regulatory_Quality_Requirements\"><\/span><strong>2. Regulatory Quality Requirements<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>NABL accreditation maintenance, CGHS panel compliance and quality audits add ongoing operational costs that weigh on margins.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Capital_Intensity_of_Network_Expansion\"><\/span><strong>3. Capital Intensity of Network Expansion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Setting up new collection centres and processing labs requires significant capital; ROI typically takes 2-3 years to fully materialise.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_Equipment_Upgrade_Capex\"><\/span><strong>4. Equipment Upgrade Capex<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Rapid diagnostic technology evolution requires continuous equipment replacement investment, adding recurring capex pressure.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_Insurance_Reimbursement_Pressure\"><\/span><strong>5. Insurance Reimbursement Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Health insurers negotiating lower reimbursement rates for diagnostic tests can reduce revenue per test over time.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Krsnaa_Diagnostics_Share_Price_and_Analyst_Ratings\"><\/span><strong>Krsnaa Diagnostics Share Price and Analyst Ratings<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Krsnaa Diagnostics (KRSNAA) is currently trading at Rs 488 with a market capitalisation of approximately Rs 2,820 Cr. The stock has been under investor scrutiny ahead of Q4 results, with analysts closely monitoring sector trends and company-specific developments that could influence the quarterly outcome.<\/p>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<td><strong>Brokerage<\/strong><\/td>\n<td><strong>Rating<\/strong><\/td>\n<td><strong>Target Price<\/strong><\/td>\n<td><strong>Thesis<\/strong><\/td>\n<\/tr>\n<tr>\n<td>Emkay Global<\/td>\n<td><strong>Buy<\/strong><\/td>\n<td>Rs 575<\/td>\n<td>Network expansion and volume recovery on track<\/td>\n<\/tr>\n<tr>\n<td>JM Financial<\/td>\n<td><strong>Neutral<\/strong><\/td>\n<td>Rs 512<\/td>\n<td>Competition intensity remains a concern<\/td>\n<\/tr>\n<tr>\n<td>ICICI Direct<\/td>\n<td><strong>Buy<\/strong><\/td>\n<td>Rs 575<\/td>\n<td>Preventive health demand and B2B growth drivers<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Krsnaa Diagnostics share price, analyst ratings and earnings updates in real time.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Krsnaa Diagnostics heads into Q4 FY26 with reasonable earnings visibility, supported by sector tailwinds and company-specific operational improvements. The Q4 numbers will be an important validation of the full-year FY26 investment thesis. Investors should track the results date, dividend announcement and management commentary on FY27 guidance closely. For ongoing research and stock insights, visit <a href=\"https:\/\/univest.in\/blogs\">Univest Blogs<\/a>.<\/p>\n<p>This article is for informational and educational purposes only and does not constitute investment advice. All estimates are based on publicly available analyst research and are subject to change. Consult a SEBI-registered advisor before making investment decisions.<\/p>\n<p>For more Q4 FY26 results previews, visit <a href=\"https:\/\/univest.in\/blogs\">Univest Blogs<\/a>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Krsnaa_Diagnostics_Q4_results_2026_date\"><\/span><strong>What is the Krsnaa Diagnostics Q4 results 2026 date?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Krsnaa Diagnostics Q4 FY26 results are expected to be announced in May 2026. The exact date will be confirmed by the company&#8217;s board through a BSE and NSE filing. Check <a href=\"https:\/\/univest.in\/user\/log-in\">Univest<\/a> for real-time updates.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Krsnaa_Diagnostics_Q4_FY26_PAT_estimate\"><\/span><strong>What is the Krsnaa Diagnostics Q4 FY26 PAT estimate?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Analyst consensus estimates put Krsnaa Diagnostics Q4 FY26 PAT at approximately Rs 34 Cr, representing a year-on-year growth of approximately 21% compared to the same quarter in FY25. These are estimates and actual results may vary.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Krsnaa_Diagnostics_share_price_ahead_of_Q4_results\"><\/span><strong>What is Krsnaa Diagnostics share price ahead of Q4 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Krsnaa Diagnostics share price (ticker: KRSNAA) is trading near Rs 488 with a market capitalisation of approximately Rs 2,820 Cr. Investors should track the stock on <a href=\"https:\/\/univest.in\/screeners\">Univest Screener<\/a> for live price and fundamental data.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Will_Krsnaa_Diagnostics_declare_a_dividend_in_Q4_2026\"><\/span><strong>Will Krsnaa Diagnostics declare a dividend in Q4 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Based on available analyst estimates and historical dividend patterns, Nil expected. Krsnaa Diagnostics&#8217;s historical dividend record shows Nil. A final dividend announcement is typically made at the board meeting where Q4 results are declared.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_analysts_have_a_Buy_rating_on_Krsnaa_Diagnostics\"><\/span><strong>Which analysts have a Buy rating on Krsnaa Diagnostics?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Based on publicly available brokerage research, Emkay Global has a Buy rating on Krsnaa Diagnostics with the thesis: Network expansion and volume recovery on track. Ratings are subject to change; always consult a SEBI-registered advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_Krsnaa_Diagnostics_Q3_FY26_results\"><\/span><strong>What were Krsnaa Diagnostics Q3 FY26 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Krsnaa Diagnostics reported Q3 FY26 revenue of Rs 280 Cr and PAT of Rs 28 Cr. The management commentary highlighted key operational metrics and sector-specific guidance that set the expectations benchmark for Q4 FY26 performance.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"When_do_Infosys_and_TCS_announce_Q4_results_2026\"><\/span><strong>When do Infosys and TCS announce Q4 results 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><a href=\"https:\/\/univest.in\/blogs\/tcs-q4-results-2026-date-preview\">TCS announced its Q4 FY26 results on April 9, 2026<\/a>, while <a href=\"https:\/\/univest.in\/blogs\/infosys-q4-results-2026-date-preview\">Infosys announced on April 23, 2026<\/a>. These results set the broader IT sector tone and benchmark for Q4 earnings season.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Krsnaa_Diagnostics_a_good_investment_ahead_of_Q4_results\"><\/span><strong>Is Krsnaa Diagnostics a good investment ahead of Q4 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Krsnaa Diagnostics operates in the Healthcare and Diagnostics sector and its Q4 FY26 performance will be determined by the factors outlined above. Any investment decision should be based on your personal financial goals, risk tolerance and a consultation with a SEBI-registered investment advisor. Access research on <a href=\"https:\/\/univest.in\/user\/log-in\">Univest<\/a>.<\/p>\n<p><strong>Disclaimer:<\/strong> Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data and analyst estimates are sourced from publicly available information including NSE and BSE filings and company investor relations pages. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p class=\"text-xl font-bold font-Inter mb-4\"><a href=\"https:\/\/univest.in\/blogs\/kridhan-infra-q4-results-2026\">Kridhan Infra Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p class=\"text-xl font-bold font-Inter mb-4\"><a href=\"https:\/\/univest.in\/blogs\/krebs-biochemicals-and-industries-q4-results-2026\">Krebs Biochemicals and Industries Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p class=\"text-xl font-bold font-Inter mb-4\"><a href=\"https:\/\/univest.in\/blogs\/krbl-q4-results-2026-2\">KRBL Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p class=\"text-xl font-bold font-Inter mb-4\"><a href=\"https:\/\/univest.in\/blogs\/kpit-technologies-q4-results-2026-2\">KPIT Technologies Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n<p class=\"text-xl font-bold font-Inter mb-4\"><a href=\"https:\/\/univest.in\/blogs\/kothari-sugars-and-chemicals-q4-results-2026\">Kothari Sugars and Chemicals Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Get the complete Krsnaa Diagnostics Q4 Results 2026 preview including expected date, revenue estimate of Rs 308 Cr, PAT estimate of Rs 34 Cr and latest analyst ratings. Updated on Univest.<\/p>\n","protected":false},"author":28,"featured_media":76556,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3858],"class_list":["post-76110","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-q4-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1777007725:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["74"],"rank_math_title":["Krsnaa Diagnostics Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook"],"rank_math_description":["Krsnaa Diagnostics Q4 Results 2026 preview including expected date, revenue estimate of Rs 308 Cr, PAT estimate of Rs 34 Cr and latest analyst ratings. Updated on Univest."],"rank_math_focus_keyword":["Krsnaa Diagnostics Q4 Results"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_wp_old_slug":["blogs-krsnaa-diagnostics-q4-results-2026-preview"],"_wp_old_date":["2026-04-23"],"_thumbnail_id":["76556"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["9041"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/24104307\/Krsnaa-Diagnostics-Q4-Results-2026.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/76110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=76110"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/76110\/revisions"}],"predecessor-version":[{"id":76557,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/76110\/revisions\/76557"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/76556"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=76110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=76110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=76110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}